Patritumab (U3-1287) is an anti-HER3 monoclonal antibody with potential antitumor activity and inhibits phosphorylation of EGFR, HER2, HER3, ERK, and AKT.Patritumab promotes apoptosis and inhibits proliferation in non-small cell lung cancer.
CAS Number:
[1262787-83-6]
Target:
EGFR|||ERK|||HER|||Akt
* VAT and and shipping costs not included. Errors and price changes excepted